BLK vs GLUE · P/E 27, rev $24.22B vs rev $13.2M
BlackRock Inc (BLK) versus Monte Rosa Therapeutics Inc (GLUE) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. GLUE currently screens at market cap $1.56B.
Not investment advice. Open the BLK and GLUE stock pages for the full models.
Not investment advice.